London (ots/PRNewswire) - Professor Terje Pedersen (Ullevål
University Hospital, Oslo, Norway), lead investigator for the
Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) Study, will
provide an update on the study on Monday the 21st July.
Also present in London will be Sir Richard Peto (Professor of
Medical Statistics and Epidemiology and Co-director of the Clinical
Trials Service Unit, University of Oxford) Professor Rory Collins
(BHF Professor of Medicine and Epidemiology at the University of
Oxford and Co-director of the Clinical Trials Service Unit) and
Professor Ingar Holme, PhD, (Professor of Biostatistics, University
of Oslo and Ullevål University Hospital, Oslo, Norway), SEAS steering
The London panel will be joined by Professor Eugene Braunwald
(Professor of Medicine at Harvard Medical School) who will
participate via Web link from Boston and Professor Robert M Califf
(Professor of Medicine, Head of Duke Clinical Research, Duke
University) available via phone link.
You are invited to join us at:
The Hilton London Metropole Hotel,
King Suite (3rd Floor, West Wing),
225 Edgware Road, London W2 1JU
When: 21st July at 5.30pm for a 6pm start, BST
The press conference will be Webcast live, and archived,
Additionally the press conference can be accessed via satellite
and full coordinates for USA and Europe will be issued by 1pm BST.
There will be a Q&A session after the press announcement. The
Q&A session is only available for members of the media.
ots Originaltext: Prof Terje Pedersen,SEAS Study Principal Investigator & Head of Steering Committee
Im Internet recherchierbar: http://www.presseportal.ch
For further information please call: The SEAS Press Office on